Prevalence of S aureus in nose and on (un)affected skin of patients visiting the outpatient department of Dermatology.

Completed

• Conditions: S aureus carrier; 10004018; 10040790

• Registration Number: NL-OMON31481
• Lead Sponsor: Academisch Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Patients visiting the outpatient department Dermatology during the period of the research programme

Exclusion Criteria

None

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome of the study is the prevalence of S aureus. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secundary outcomes of the study comprises of the sensitivity of S aureus to<br /><br>various antibiotics and the possible risk factors for being carrier of S<br /><br>aureus. </p><br>